Measurement of acute phase proteins in the rat brain: Contribution of vascular contents

Neurochemical Research

Volumn 24, Issue 10, 1999, Pages 1313-1317

  Loeffler, David A ^a,d   Linder, Maria C ^b   Zamany, Mehran ^b   Harel, Eli ^a   Paul, Michael A ^a   Baumann, Heinz ^c   LeWitt, Peter A ^a,d  

^a SINAI GRACE HOSPITAL   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase proteins; Alzheimer's disease; Ceruloplasmin; Complement factor 3; Copper; Interleukin 1

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COPPER; HAPTOGLOBIN; INTERLEUKIN 1BETA; PHOSPHATE;

ACUTE PHASE RESPONSE; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN; BRAIN BLOOD VESSEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOELECTROPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0032852651     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020989426694     Document Type: Article

References (24)

1. Kushner, I. 1982. The phenomenon of the acute phase response. Ann. N.Y. Acad. Sci., 389:39-48.
2. Koj, A. 1985. Definition and classification of acute phase proteins. Pages 139-232, in Gordon, A. H., and Koj, A. (eds.), The Acute Phase Response in Injury and Infection, vol. 10, Elsevier, Amsterdam.
3. Baumann, H., Prowse, K. R., Marinkovic, S., Won, K.-A., and Jahreis, G. P. 1989. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N.Y. Acad. Sci., 557: 280-296.
4. Abraham, C. R., and Potter, H. P. 1989. The protease inhibitor, α-1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease. Ann. Med., 21: 77-81.
5. Eikelenboom, P., Hack, C. E., Rozemuller, J. M., and Stam, F. C. 1989. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Archiv. B Cell Path., 56:259-262.
6. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., and Berger, M. 1991. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett., 285:111-114.
7. Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Sima, A. A. F., Nguyen, H.-U., DeMaggio, A. J., Brickman, C. M., Brewer, G. J., Dick, R. D., and Kanaley, L. 1996. Increased ceruloplasmin concentrations in Alzheimer's and Parkinson's disease brain regions. Brain Res., 738:265-274.
8. Sheng, J. G., Mrak, R. E., and Griffin, W. S. T. 1995. Microglial interleukin-1-α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropath. Appl. Neurobiol., 21:290-301.
9. + astrocytes with neurofibrillary tangle stages. J. Neuropath. Exp. Neurol., 56:285-290.
10. 2-macroglobulin and C-reactive protein. Brain Res., 629:245-252.
11. Middleton, R. B., and Linder, M. C. 1993. Synthesis and turnover of ceruloplasmin in rats treated with 17-β estradiol. Arch. Biochem. Biophys., 302:362-368.
12. Baumann, H. 1988. Electrophoretic analysis of acute phase plasma proteins. Methods Enzymol., 163:566-594.
13. Tran, T. N., Schaffer, K. J., Eubanks, S., Zhou, C. Y. I., and Linder, M. C. 1997. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood, 90:4979-4986.
14. Linder, M., and Hazegh-Azam, M. 1996. The biochemistry and molecular biology of copper. Am. J. Clin. Nutr., (supplement) 63:797S-811S.
15. Cleveland, W. S. 1993. Visualizing Data, pages 25-27, Hobart Press, Summit.
16. Fairbanks, V. F. 1976. Hemoglobin, hemoglobin derivatives and myoglobin, Pages 411-414, in Tietz, N. W. (ed.), Fundamentals of Clinical Chemistry, W. B. Saunders, Philadelphia.
17. Aldred, A. R., Brack, C. M., and Schreiber, G. 1995. The cerebral expression of plasma protein genes in different species. Comp. Biochem. Physiol., 111B:1-15.
18. Connor, J. R., Tucker, P., Johnson, M., and Snyder, B. 1993. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci. Lett., 159:88-90.
19. Terai, K., Walker, D. G., McGeer, E. G., and McGeer, P. L. 1997. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res., 769:385-390.
20. Dickson, D., and Rogers, J. 1992. Neuroimmunology of Alzheimer's disease: a conference report. Neurobiol. Aging 13:793-798.
21. Walker, D. G., and McGeer, P. L. 1992. Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Mol. Brain. Res., 14:109-116.
22. Henry, J. B. 1991. Clinical Diagnosis and Management by Laboratory Methods, Pages 1367-1372. W. B. Saunders Co., Philadelphia.
23. van Deuren, M., van der Ven-Jongekrijg, J., Vannier, E., van Dalen, R., Pesman, G., Bartelink, A. K. M., Dinarello, C. A., and van der Meer, J. W. M. 1997. The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood, 90:1101-1108.
24. Jacobs, D. S., Kasten, B. L. Jr., DeMott, W. R., and Wolfson, W. L. 1984. Laboratory Test Handbook with DRG Index, Page 376, Mosby/Lexi-Comp, St. Louis.